GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023

Galectin Therapeutics (NASDAQ:GALT) just reported results for the fourth quarter of 2023.Galectin Therapeutics reported earnings per share of -16 cents. This met the analyst estimate for EPS of -16 cents.The company did not report any revenue for the quarter.InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to ana ...